Absence of distinguishing senescence traits in human melanocytic nevi (Q39362670)

11 September 2017

Absence of distinguishing senescence traits in human melanocytic nevi (English)

1 reference

11 September 2017

8

1 reference

11 September 2017

Sieu L Tran

1

1 reference

11 September 2017

Sebastian Haferkamp

2

1 reference

11 September 2017

Lyndee L Scurr

3

1 reference

11 September 2017

Kavitha Gowrishankar

4

1 reference

11 September 2017

Therese M Becker

5

1 reference

11 September 2017

Chitra Desilva

6

1 reference

11 September 2017

John F Thompson

7

1 reference

11 September 2017

Richard F Kefford

9

1 reference

11 September 2017

Helen Rizos

10

1 reference

11 September 2017

language of work or name

English

0 references

publication date

19 April 2012

1 reference

Journal of Investigative Dermatology

11 September 2017

1 reference

11 September 2017

132

1 reference

11 September 2017

9

1 reference

11 September 2017

2226-2234

1 reference

https://scigraph.springernature.com/pub.10.1038/jid.2012.126

11 September 2017

0 references

cites work

Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Cutaneous melanomas associated with nevi

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Cellular senescence: when bad things happen to good cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Melanocytic nevi in pregnancy: histologic features and Ki-67 proliferation index

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

The power and the promise of oncogene-induced senescence markers.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Absence of senescence-associated beta-galactosidase activity in human melanocytic nevi in vivo

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

A negative feedback signaling network underlies oncogene-induced senescence

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

p53 Protein Expression in Nevi and Melanomas

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Spitz naevus: diagnostic problems and their management implications

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Oncogenic Braf induces melanocyte senescence and melanoma in mice

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

A biomarker that identifies senescent human cells in culture and in aging skin in vivo

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Dysplastic nevus in histologic contiguity with acquired nonfamilial melanoma. Clinicopathologic experience in a 100-bed hospital

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Differential roles of the pRb and Arf/p53 pathways in murine naevus and melanoma genesis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Failure to Detect Differences in Proliferation Status of Nevi from CDKN2A Mutation Carriers and Non-Carriers

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Proliferation, apoptosis, and survivin expression in a spectrum of melanocytic nevi

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Frequent mitotic activity in banal melanocytic nevi uncovered by immunohistochemical analysis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Cellular senescence in naevi and immortalisation in melanoma: a role for p16?

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Oncogene-induced senescence does not require the p16(INK4a) or p14ARF melanoma tumor suppressors.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Human melanocytes cultured from nevi and melanomas

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Proliferative activity in Spitz's naevi compared with other melanocytic skin lesions

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Mitoses in conventional melanocytic nevi.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

The essence of senescence

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Proliferative activity of primary cutaneous melanocytic tumours

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

The significance of Ki-67 proliferative index and cyclin D1 expression of dysplastic nevi in the biologic spectrum of melanocytic lesions

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Polyclonality of BRAF mutations in acquired melanocytic nevi

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

BRAF kinase gene V599E mutation in growing melanocytic lesions

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Mechanisms of cell-cycle arrest in Spitz nevi with constitutive activation of the MAP-kinase pathway

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Do all melanomas come from "moles"? A study of the histological association between melanocytic naevi and melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Comment on “Absence of Senescence-Associated β-Galactosidase Activity in Human Melanocytic Nevi In Vivo”

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

BRAFE600-associated senescence-like cell cycle arrest of human naevi

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Quantitative in situ evaluation of telomeres in fluorescence in situ hybridization-processed sections of cutaneous melanocytic lesions and correlation with telomerase activity.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Oncogene-induced cell senescence--halting on the road to cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Ki67 Antigen Expression Correlates with Tumor Progression and HLA-DR Antigen Expression in Melanocytic Lesions

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Cellular senescence: molecular mechanisms, in vivo significance, and redox considerations

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

High frequency of BRAF mutations in nevi

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Proliferation marker Ki-S5 as a diagnostic tool in melanocytic lesions

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Enhanced expression of Ki-67, topoisomerase IIalpha, PCNA, p53 and p21WAF1/Cip1 reflecting proliferation and repair activity in UV-irradiated melanocytic nevi

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Mitotic activity within dermal melanocytes of benign melanocytic nevi: a study of 100 cases with clinical follow-up

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Incomplete biopsy of melanocytic lesions can impair the accuracy of pathological diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Pathology of melanocytic lesions: new, controversial, and clinically important issues.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

IGFBP7 is not required for B-RAF-induced melanocyte senescence

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Is beta-galactosidase staining a marker of senescence in vitro and in vivo?

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Persistent melanocytic nevi: a review and analysis of 205 cases

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progression

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Proliferation antigens in cutaneous melanocytic tumors--an immunohistochemical study comparing the transferrin receptor and the Ki 67 antigen

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

One single erythemagenic UV irradiation is more effective in increasing the proliferative activity of melanocytes in melanocytic naevi compared with fractionally applied high doses

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

The dermoscopical and histopathological patterns of nevi correlate with the frequency of BRAF mutations.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.126

7 January 2021

Identifiers

DOI

10.1038/JID.2012.126

1 reference

Dimensions Publication ID

11 September 2017

0 references

1 reference